{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:40:28Z","timestamp":1767919228658,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T00:00:00Z","timestamp":1637452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T00:00:00Z","timestamp":1637452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"national health and medical research council","doi-asserted-by":"publisher","award":["APP2005244"],"award-info":[{"award-number":["APP2005244"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"national health and medical research council","doi-asserted-by":"publisher","award":["APP1195414"],"award-info":[{"award-number":["APP1195414"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Gastro-intestinal (GI) intolerance is a frequently reported outcome in patients with kidney failure receiving maintenance dialysis and those who have received kidney transplants. Symptoms of GI intolerance (diarrhoea, constipation, bloating, abdominal pain, heart burn, and reflux) are associated with significant reduction in quality of life, morbidity, and increased used of healthcare resources. Having chronic kidney disease (CKD), together with related changes in diet and medication, may alter the gut microbiota and the microbial-derived uraemic metabolites that accumulate in kidney failure, and contribute to various complications including chronic diarrhoea, opportunistic infections, and drug-related colitis. Despite the high disease burden among patients with kidney replacement therapies, GI symptoms are often under-recognised and, consequently limited resources and strategies are devoted to the management of gastrointestinal complications in patients with CKD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The CKD Bowel Health Study is a multi-centre mixed-methods observational longitudinal study to better understand the bowel health and GI symptom management in patients with CKD. The program comprises of a longitudinal study that will assess the burden and risk factors of GI intolerance in patients treated with maintenance dialysis; a semi-structured interview study that will describe experiences of GI intolerance (including symptoms, treatment, self-management) in transplant candidates and recipients; and a discrete choice experience to elicit patient preferences regarding their experiences and perspectives of various intervention strategies for the management of GI symptoms after kidney transplantation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>This proposed program of work aims to define the burden the GI intolerance in patients with kidney failure and generate evidence on the patients\u2019 experiences of GI intolerance and their perspectives on their clinical and own management strategies of these symptoms, ensuring a patient-centred approach to guide clinical decision making and to inform the best study design for intervention trials.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>This study is registered on the Australian New Zealand Clinical Trials Registry (ANZCTR): <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=381075&amp;isClinicalTrial=False\">ACTRN12621000548831<\/jats:ext-link>. This study has been approved by the Western Sydney Local Health District Human Research Ethics Committee of New South Wales Health (HREC ETH03007). This study is supported by a National Health and Medical Research Council (NHMRC) Australia Investigator Grant (APP1195414), and an NHMRC Australia Postgraduate Scholarship (APP2005244).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-021-02600-x","type":"journal-article","created":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T21:05:42Z","timestamp":1637528742000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The CKD bowel health study: understanding the bowel health and gastrointestinal symptom management in patients with chronic kidney disease: a mixed-methods observational longitudinal study (protocol)"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7050-3103","authenticated-orcid":false,"given":"Tess E.","family":"Cooper","sequence":"first","affiliation":[]},{"given":"Amy","family":"Dalton","sequence":"additional","affiliation":[]},{"given":"Anh","family":"Kieu","sequence":"additional","affiliation":[]},{"given":"Martin","family":"Howell","sequence":"additional","affiliation":[]},{"given":"Sumedh","family":"Jayanti","sequence":"additional","affiliation":[]},{"given":"Rabia","family":"Khalid","sequence":"additional","affiliation":[]},{"given":"Wai H.","family":"Lim","sequence":"additional","affiliation":[]},{"given":"Nicole","family":"Scholes-Robertson","sequence":"additional","affiliation":[]},{"given":"Jonathan C.","family":"Craig","sequence":"additional","affiliation":[]},{"given":"Armando","family":"Teixeira-Pinto","sequence":"additional","affiliation":[]},{"given":"Michael J.","family":"Bourke","sequence":"additional","affiliation":[]},{"given":"Allison","family":"Tong","sequence":"additional","affiliation":[]},{"given":"Germaine","family":"Wong","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,11,21]]},"reference":[{"issue":"6","key":"2600_CR1","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/j.1399-0012.2005.00421.x","volume":"19","author":"J Tierce","year":"2005","unstructured":"Tierce J, Porterfield-Baxa J, Petrilla A, Kilburg A, Ferguson R. Impact of mycophenolate mofetil (MMF)-related gastrointestinal complications and MMF dose alterations on transplant outcomes and healthcare costs in renal transplant recipients. Clin Transpl. 2005;19(6):779\u201384.","journal-title":"Clin Transpl"},{"issue":"1","key":"2600_CR2","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.healun.2007.10.012","volume":"27","author":"P Galiwango","year":"2008","unstructured":"Galiwango P, Delgado D, Yan R, Kozuszko S, Smith R, Rao V, et al. Mycophenolate mofetil dose reduction for gastrointestinal intolerance is associated with increased rates of rejection in heart transplant patients. J Heart Lung Transplant. 2008;27(1):72\u20137.","journal-title":"J Heart Lung Transplant"},{"issue":"9","key":"2600_CR3","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1097\/01.ASN.0000079616.71891.F5","volume":"14","author":"G Knoll","year":"2003","unstructured":"Knoll G, MacDonald I, Khan A, Van Walraven C. Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation. J Am Soc Neph. 2003;14(9):2381\u20136.","journal-title":"J Am Soc Neph"},{"issue":"4","key":"2600_CR4","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/TP.0b013e3181ca860d","volume":"89","author":"H Sollinger","year":"2010","unstructured":"Sollinger H, Sundberg A, Leverson G, Voss B, Pirsch J. Mycophenolate mofetil versus enteric-coated mycophenolate sodium: a large, single-center comparison of dose adjustments and outcomes in kidney transplant recipients. Transplantation. 2010;89(4):446\u201351.","journal-title":"Transplantation"},{"key":"2600_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1477-7525-6-53","volume":"6","author":"G Machnicki","year":"2008","unstructured":"Machnicki G, Pefaur J, Gaite L, Linchenco A, Raimondi C, Schiavelli K, et al. Gastrointestinal (GI)-specific patient reported outcomes instruments differentiate between renal transplant patients with or without GI symptoms: results from a south American cohort. Health Qual Life Outcomes. 2008;6:53.","journal-title":"Health Qual Life Outcomes"},{"issue":"11","key":"2600_CR6","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1111\/j.1432-2277.2010.01115.x","volume":"23","author":"C Ponticelli","year":"2010","unstructured":"Ponticelli C, Colombo D, Novara M, Basilisco G, Group C. Gastrointestinal symptoms impair quality of life in Italian renal transplant recipients but are under-recognized by physicians. Transpl Int. 2010;23(11):1126\u201334.","journal-title":"Transpl Int"},{"issue":"6","key":"2600_CR7","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/j.1399-0012.2005.00421.x","volume":"19","author":"K Budde","year":"2005","unstructured":"Budde K, Curtis J, Knoll G, Chan L, Neumayer H, Seifu Y, et al. Enteric-coated mycophenolate mofetil (MMF)-related gastrointestinal complications and MMF dose alterations on transplant outcomes and healthcare costs in renal transplant recipients. Clin Transpl. 2005;19(6):779\u201384.","journal-title":"Clin Transpl"},{"key":"2600_CR8","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.2147\/PPA.S145648","volume":"12","author":"EM Umeukeje","year":"2018","unstructured":"Umeukeje EM, Mixon AS, Cavanaugh KL. Phosphate-control adherence in hemodialysis patients: current perspectives. Patient Preference Adherence. 2018;12:1175\u201391.","journal-title":"Patient Preference Adherence"},{"key":"2600_CR9","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41581-019-0172-1","volume":"15","author":"B Meijers","year":"2019","unstructured":"Meijers B, Evenepoel P, Anders H. Intestinal microbiome and fitness in kidney disease. Nat Rev Nephrol. 2019;15:531\u201345.","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"2600_CR10","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/TP.0000000000000370","volume":"98","author":"J Lee","year":"2014","unstructured":"Lee J, Muthukumar T, Dadhania D, Toussaint N, Ling L, Pamer E, et al. Gut microbioal community structure and complications after kidney transplantation: a pilot study. Transplantation. 2014;98(7):697\u2013705.","journal-title":"Transplantation"},{"issue":"3","key":"2600_CR11","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1681\/ASN.2018090906","volume":"30","author":"E Au","year":"2019","unstructured":"Au E, Chapman J, Craig J, Lim W, Teixeira-Pinto A, Ullah S, et al. Overall and site-specific cancer mortality in patients on dialysis and after kidney transplant. J Am Soc Nephrol. 2019;30(3):471\u201380.","journal-title":"J Am Soc Nephrol"},{"key":"2600_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2215\/CJN.05240515","volume":"11","author":"M Rossi","year":"2016","unstructured":"Rossi M, Johnson D, Morrison M, Pascoe E, Coombes JS, Forbes JM, et al. Synbiotics easing renal failure by improving gut microbiology (SYNERGY): a randomized trial. CJASN. 2016;11:223\u201331.","journal-title":"CJASN"},{"key":"2600_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/586939","volume":"2014","author":"M Valentini","year":"2014","unstructured":"Valentini M, Piermattei A, Di Sante G, Migliara G, Delogu G, Ria F. Immunomodulation by gut microbiota: role of toll-like receptor expressed by T cells. J Immunol Res. 2014;2014:586939.","journal-title":"J Immunol Res"},{"issue":"4","key":"2600_CR14","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"2600_CR15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357.","journal-title":"Int J Qual Health Care"},{"key":"2600_CR16","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","volume":"158","author":"P Stevens","year":"2013","unstructured":"Stevens P, Levin A. Evaluation and Management of Chronic Kidney Disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158:825\u201330.","journal-title":"Ann Intern Med"},{"key":"2600_CR17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3109\/07853890109002087","volume":"33","author":"R Rabin","year":"2001","unstructured":"Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol group [review]. Ann Med. 2001;33:337\u201343.","journal-title":"Ann Med"},{"issue":"9","key":"2600_CR18","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3109\/00365529709011203","volume":"32","author":"S Lewis","year":"1997","unstructured":"Lewis S, Heaton K. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32(9):920\u20134.","journal-title":"Scand J Gastroenterol"},{"issue":"11","key":"2600_CR19","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.3109\/00365529509101605","volume":"30","author":"E Dimenas","year":"1995","unstructured":"Dimenas E, Glise H, Hallerback B, Hernqvist H, Svedlund J, Wiklund I. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol. 1995;30(11):1046\u201352.","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"2600_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1023\/A:1008841022998","volume":"7","author":"D Revicki","year":"1997","unstructured":"Revicki D, Wood M, Wiklund I, Crawley J. Reliability and validity of the gastrointestinal symptom rating scale in patients with gastroesophageal reflux disease. Qual Life Res. 1997;7(1):75\u201383.","journal-title":"Qual Life Res"},{"issue":"2","key":"2600_CR21","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/bjs.1800820229","volume":"82","author":"E Eypasch","year":"1995","unstructured":"Eypasch E, Williams J, Wood-Dauphinee S, Ure B, Schm\u00fclling C, Neugebauer E, et al. Gastrointestinal quality of life index: development, validation and application of a new instrument. Br J Surg. 1995;82(2):216\u201322.","journal-title":"Br J Surg"},{"issue":"13","key":"2600_CR22","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1017\/S1368980016000690","volume":"19","author":"J Bassett","year":"2016","unstructured":"Bassett J, English D, Fahey M, Forbes A, Gurrin L, Simpson J, et al. Validity and calibration of the FFQ used in the Melbourne collaborative cohort study. Public Health Nutr. 2016;19(13):2357\u201368.","journal-title":"Public Health Nutr"},{"issue":"2","key":"2600_CR23","doi-asserted-by":"publisher","first-page":"pISSN2093","DOI":"10.5056\/jnm.2013.19.2.137","volume":"19","author":"B Spiegel","year":"2013","unstructured":"Spiegel B. Patient-reported outcomes in gastroenterology: clinical and research applications. J Neurogastroenterol Motil. 2013;19(2):pISSN2093\u20130879.","journal-title":"J Neurogastroenterol Motil"},{"issue":"7","key":"2600_CR24","first-page":"30158765","volume":"11","author":"NR Hill","year":"2016","unstructured":"Hill NR, Fatoba ST, Oke JL, Hirst JA, O'Callaghan CA, Lasserson DS, et al. Global prevalence of chronic kidney disease - a systematic review and meta-analysis. PLoS One. 2016;11(7):30158765.","journal-title":"PLoS One"},{"issue":"12","key":"2600_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0225722","volume":"14","author":"J Hughes","year":"2019","unstructured":"Hughes J, Freeman N, Beaton B, Puruntatemeri A, Hausin M, Tipiloura G, et al. My experiences with kidney care: a qualitative study of adults in the Northern Territory of Australia living with chronic kidney disease, dialysis and transplantation. PLoS One. 2019;14(12):1\u201315.","journal-title":"PLoS One"},{"issue":"3","key":"2600_CR26","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1053\/j.ajkd.2014.07.019","volume":"65","author":"M Medway","year":"2015","unstructured":"Medway M, Tong A, Craig J, Kim S, Mackie F, McTaggart S, et al. Parental perspectives on the financial impact of caring for a child with CKD. AJKD. 2015;65(3):384\u201393.","journal-title":"AJKD"},{"key":"2600_CR27","doi-asserted-by":"publisher","first-page":"443","DOI":"10.2215\/CJN.05890616","volume":"12","author":"J Pinter","year":"2017","unstructured":"Pinter J, Hanson C, Chapman J, Wong G, Craig J, Schell J, et al. Perspectives of older kidney transplant recipients on kidney transplantation. CJASN. 2017;12:443\u201353.","journal-title":"CJASN"},{"issue":"6","key":"2600_CR28","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1053\/j.jrn.2018.02.005","volume":"28","author":"J Stevens","year":"2018","unstructured":"Stevens J, Tong A, Gutman T, Campbell K, Craig J, Brown M, et al. Experiences and perspectives of dietary management among patients on hemodialysis: an interview study. J Ren Nutr. 2018;28(6):411\u201321.","journal-title":"J Ren Nutr"},{"key":"2600_CR29","doi-asserted-by":"publisher","first-page":"454","DOI":"10.2215\/CJN.08370816","volume":"12","author":"A Tong","year":"2017","unstructured":"Tong A, Winkelmayer W, Wheeler D, van Biesen W, Tugwell P, Manns B, et al. Nephrologists\u2019 perspectives on defining and applying patient-centered outcomes in hemodialysis. CJASN. 2017;12:454\u201366.","journal-title":"CJASN"},{"key":"2600_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-021198","volume":"8","author":"A Tong","year":"2018","unstructured":"Tong A, Crowe S, Gill J, Harris T, Hemmelgarn B, Manns B, et al. Clinicians\u2019 and researchers\u2019 perspectives on establishing and implementing core outcomes in haemodialysis: semistructured interview study. BMJ Open. 2018;8:e021198.","journal-title":"BMJ Open"},{"issue":"3","key":"2600_CR31","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1053\/j.ajkd.2014.08.011","volume":"65","author":"S Tonkin-Crine","year":"2015","unstructured":"Tonkin-Crine S, Okamoto I, Leydon G, Murtagh F, Farrington K, Caskey F, et al. Understanding by older patients of Dialysis and conservative Management for Chronic Kidney Failure. AJKD. 2015;65(3):443\u201350.","journal-title":"AJKD"},{"key":"2600_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-013829","volume":"7","author":"R Walker","year":"2017","unstructured":"Walker R, Walker S, Morton R, Tong A, Howard K, Palmer S. BMJ Open. 2017;7:e013829.","journal-title":"BMJ Open"},{"key":"2600_CR33","doi-asserted-by":"publisher","first-page":"100","DOI":"10.2215\/CJN.06830617","volume":"13","author":"R Walker","year":"2017","unstructured":"Walker R, Morton R, Palmer S, Marshall M, Tong A, Howard K. A discrete choice study of patient preferences for Dialysis modalities. CJASN. 2017;13:100\u20138.","journal-title":"CJASN"},{"issue":"Suppl 3","key":"2600_CR34","first-page":"S137","volume":"67","author":"S Brunet-Houdard","year":"2019","unstructured":"Brunet-Houdard S, Monmousseau F, Rusch E, Giral M, Tessier P. A discrete choice experiment to explore patients\u2019 preferences for kidney transplant monitoring by teleconsultation. J Epidemiol Community Health. 2019;67(Suppl 3):S137\u20138.","journal-title":"J Epidemiol Community Health"},{"key":"2600_CR35","doi-asserted-by":"crossref","unstructured":"Clark M, Leech D, Gumber A, Moro D, Szczepura A, West N, et al. Who should be prioritized for renal transplantation?: analysis of key stakeholder preferences using discrete choice experiments. BMC Nephrol. 2012;13(152).","DOI":"10.1186\/1471-2369-13-152"},{"key":"2600_CR36","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/ndt\/gfw436","volume":"33","author":"M Clark","year":"2018","unstructured":"Clark M, Szczepura A, Gumber A, Howard K, Moro D, Morton R. Measuring trade-offs in nephrology: a systematic review of discrete choice experiments and conjoint analysis studies. Neph Dial Transplant. 2018;33:348\u201355.","journal-title":"Neph Dial Transplant"},{"key":"2600_CR37","volume-title":"NLOGIT","author":"Econometric Software","year":"2016","unstructured":"Econometric Software. NLOGIT. 2016. www.limdep.com\/products\/nlogit\/ (accessed June 2021)."},{"key":"2600_CR38","doi-asserted-by":"crossref","unstructured":"Lancsar E, Fiebig DG, Hole AR. Discrete Choice Experiments: A Guide to Model Specification, Estimation and Software. Lancsar. 2017;35:697-716.","DOI":"10.1007\/s40273-017-0506-4"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02600-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-021-02600-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02600-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T21:06:56Z","timestamp":1637528816000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-021-02600-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,21]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2600"],"URL":"https:\/\/doi.org\/10.1186\/s12882-021-02600-x","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,21]]},"assertion":[{"value":"30 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been approved by the Western Sydney Local Health District Human Research Ethics Committee of New South Wales Health (HREC ETH03007) to be conducted at Westmead Hospital, New South Wales, Australia, and Sir Charles Gairdner Hospital, Perth, Western Australia, Australia. Informed consent was written where possible and to ensure COVID-19-safe practices, we will allow for video or phone verbal consent as approved by the ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"388"}}